We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > adolescents

News List

Pfizer and BioNTech’s Covid-19 vaccine shows 100% efficacy in adolescents pharmaceutical-technology
April 02, 2021
Pfizer and BioNTech have reported that a Phase III trial of their Covid-19 vaccine, BNT162b2, showed 100% efficacy and strong antibody responses in adolescents aged 12 to 15 years with or without prior evidence of SARS-CoV-2 infection.
Pfizer COVID-19 vaccine safe, efficacious for adolescents expresspharma
April 02, 2021
Whether COVID-19 vaccines work and are safe to use on children is one of the big questions drugmakers are trying to answer.
80 adolescents a day will still die of AIDS by 2030, despite slowdown in epidemic: UN biospectrumasia
December 03, 2018
Currently, 3 million persons 19 years and younger, are infected with HIV worldwide
FDA grants priority review for Dupixent® (dupilumab) as potential treatment for adolescents with uncontrolled moderate-to-severe atopic dermatitis November 10, 2018
The sBLA is supported by data from a pivotal Phase 3 trial evaluating the efficacy and safety of Dupixent monotherapy in adolescent patients with moderate-to-severe atopic dermatitis, which were presented at the European Academy of Dermatology and Venereo